Last update 08 May 2025

ONO-2910

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Action
stimulants
Mechanism
Cell differentiation stimulants
Therapeutic Areas
NeoplasmsNervous System DiseasesEndocrinology and Metabolic Disease+ [1]
Active Indication
Breast CancerDiabetic Neuropathies
Inactive Indication
Peripheral Nerve Injuries
Originator Organization
Ono Pharmaceutical Co., Ltd.Ono Pharmaceutical Co., Ltd.
Active Organization
Ono Pharmaceutical Co., Ltd.Ono Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with ONO-2910
NCT06538272
/ CompletedPhase 2
An Early Phase II, Multicenter, Placebo-Controlled, Randomized, Double-Blind, Parallel-Group, Comparison Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel
JPRN-jRCT2061210008
/ Not yet recruitingPhase 2IIT
ONO-2910-02: A Phase IIa Study of ONO-2910, Randomised, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial in Patients with Diabetic Polyneuropathy
NCT04504760
/ CompletedPhase 1
Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and PK of ONO-2910 in Japanese and Caucasian Subjects
100 Clinical Results associated with ONO-2910
Login to view more data
100 Translational Medicine associated with ONO-2910
Login to view more data
100 Patents (Medical) associated with ONO-2910
Login to view more data
100 Deals associated with ONO-2910
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 2
Japan
Ono Pharmaceutical Co., Ltd.Ono Pharmaceutical Co., Ltd.
31 Aug 2023
Diabetic NeuropathiesPhase 2
Japan
Ono Pharmaceutical Co., Ltd.Ono Pharmaceutical Co., Ltd.
-
Peripheral Nerve InjuriesPreclinical
Japan
Ono Pharmaceutical Co., Ltd.Ono Pharmaceutical Co., Ltd.
24 Aug 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free